Firestein G. - Etiology and pathogenisis of rheumatoid arthritis. In Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS Eds, Kelleys' texbook of rheumatology, 8 th ed, Saunders Elsevier, Philadelphie, 2009, 1035-1086.
Tassiulas IO, Boumpas DT. - Clinical features and treatment of systemic lupus erythematosus. In Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS Eds, Kelleys' texbook of rheumatology, 8 th ed, Saunders Elsevier, Philadelphie, 2009, 1263-1300.
Natour J. - A study of synovial membrane of patients with systemic lupus erythematosus (SLE). Clin Exp Rheumatol, 1991, 9, 221-225.
Nzeusseu Toukap A, Galant C, Theate I, et al. - Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum, 2007, 56, 1579-1588. (Pubitemid 46764087)
Williams EL, Gadola S, Edwards CJ. - Anti-TNF-induced lupus. Rheumatology, 2009, 48, 716-720.
Arnett FC, Edworthy SM, Bloch DA, et al. - The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, 1988, 31, 315-324. (Pubitemid 18091653)
Aletaha D, Neogi T, Silman AJ, et al. - 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis, 2010, 69, 1580-1588.
Hochberg MC. - Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40, 1725.
Petri, Michelle, Systemic Lupus International Collaborating Clinic (SLICC). - SLICC revision of the ACR classification criteria for SLE. American College of Rheumatology. Arthritis Rheum, 2009, 59, Abstract 895.
Vitali C. - Classification criteria for Sjögren's syndrome. Ann Rheum Dis, 2003, 62, 94.
Uetrecht J. - Current trends in drug-induced autoimmunity. Autoimmun Rev, 2005, 4, 309-314.
Desai SB, Furst DE. - Problems encountered during antitumour necrosis factor therapy. Best Pract Res Clin Rheumatol, 2006, 20, 757-790. (Pubitemid 44350122)
Charles PJ, Smeenk RJ, De Jong J, et al. - Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum, 2000, 43, 2383-2390.
Ramos-Casals M, Brito-Zerón P, Munoz S, et al. - Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine, 2007, 86, 242-251. (Pubitemid 47067483)
Costa MF, Said NR, Zimmermann B. - Drug-induced lupus due to anti-tumor necrosis factor alpha agents. Semin Arthritis Rheum, 2008, 37, 381-387. (Pubitemid 351734520)
Toone EC, Irby R, Pierce EL. - The L.E. cell in rheumatoid arthritis. Am J Med Sci, 1960, 240, 599-608.
Icen M, Nicola PJ, Maradit H, et al. - Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality. J Rheumatol, 2009, 36, 50-57.
Cohen MG, Webb J. - Concurrence of rheumatoid arthritis and systemic lupus erythematosus : report of 11 cases. Ann Rheum Dis, 1987, 46, 853-858. (Pubitemid 17155440)
van der Helm-van Mil AH, Verpoort KN, Breedveld FC, et al. - The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum, 2006, 54, 1117-1121. (Pubitemid 43672924)
Syversen SW, Gaarder PI, Goll GL, et al. - High anti-cyclic citrullinated peptide levels and an algorythm of four variables predict radiographic progression in patients with rheumatoid arthritis : results from a 10-year longitudinal study. Ann Rheum Dis, 2008, 67, 212-217. (Pubitemid 351183310)
Chan MT, Owen P, Dunphy J, et al. - Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. J Rheumatol, 2008, 35, 77-83.
Mediwake R, Isenberg DA, Schellekens GA, et al. - Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis, 2001, 60, 67-68. (Pubitemid 32038957)
Martinez JB, Valero JS, Bantista AJ, et al. - Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature. Clin Exp Rheumatol, 2007, 25, 47-53. (Pubitemid 46477485)
Zhao Y, Li J, Li XX, et al. - What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus ? Joint Bone Spine, 2009, 76, 501-507.
Qing YF, Zhang QB, Zhou JG, et al. - The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus. Lupus, 2009, 18, 713-717.
Mohammed K, Pope J, Le Riche N, et al. - Association of severe inflammatory polyarthritis in primary Sjögren's syndrome : clinical, serologic, and HLA analysis. J Rheumatol, 2009, 36, 1937-1942.
Atzeni F, Sarzi-Puttini P, Lama N, et al. - Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis. Arthritis Res Ther, 2008, 10, R51.
Schur PH. - Systemic lupus erythematosus. In Cecil-Loeb Texbook of Medicine Beeson PB, McDermott W (eds) Philadelphia, PA 1971, 821.
Amezcua-Guerra LM, Márquez-Velasco R, Bojalil R, et al. - Erosive arthritis in systemic lupus erythematosus is associated with high serum C-reactive protein and anti-cyclic citrullinated peptide antibodies. Inflamm Res, 2008, 57, 555-557.
van Vugt RM, Derksen RH, Kater L, et al. - Deforming arthropathy or lupus and rhupus hands in systemic lupus erythematosus. Ann Rheum Dis, 1998, 57, 540-544. (Pubitemid 28474061)
Damián-Abrego GN, Cabiedes J, Cabral AR, et al. - Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy. Lupus, 2008, 17, 300-304. (Pubitemid 351655797)
Brand CA, Rowley MJ, Tait BD, at al. - Coexistent rheumatoid arthritis and systemic lupus erythematosus : clinical, serological, and phenotypic feature. Ann Rheum Dis, 1992, 51, 173-176.
Simon JA, Granados J, Cabiedes J, et al. - Clinical and immunogenetic characterization of Mexican patients with 'rhupus'. Lupus, 2002, 11, 287-292. (Pubitemid 34627430)
Sparsa L, Sordet C, Chatelus H, et al. - Caractéristiques clinico-biologiques et radiologiques du rhupus : résultat d'une cohorte de 28 patients. Snfi.org/Data/moduleProgramme/PageSite/resume/5380.asp
Younes M, Korbaa W, Zrour S, et al. - Association polyarthrite rhumatoïde-lupus d'évolution fatale. Rev Rhum Mal Ostéo, 2007, 74, 1195-1196.
Meyer O, Kahn MF. - Lupus érythémateux systémique. In Kahn MF, Peltier A-P, Meyer O, Piette J-C Eds. Maladies et syndromes systémiques. 4ème ed, Médecine-Sciences Flammarion, Paris, 2000, 132-368bis.
Bardin T, Bouchaud-Chabot A. - Manifestations systémiques de la polyarthrite rhumatoïde. In Kahn MF, Peltier A-P, Meyer O, Piette J-C Eds, Maladies et syndromes systémiques, 4ème ed, Médecine-Sciences Flammarion, Paris, 2000, 397-432.
Harley JB, Alexander EL, Bias WB, et al. - Anti-Ro (SSA) and anti-La (SSB) in patients with Sjögren's syndrome. Arthritis Rheum, 1986, 29, 196-206. (Pubitemid 17022820)
Tzioufas AG, Youinou P, Moutsopoulos HM. - Sjögren's syndrome. In Maddison PJ, Isenberg DA, Woo P, Glass DN Eds, Oxford Textbook of Rheumatology ue. In Kahn MF, Peltier A-P, Meyer O, Piette J-C Eds, Maladies et syndromes systémiques, 4ème ed, Médecine-Sciences Flammarion, Paris, 2000, 132-368bis., 2 th ed, Oxford medical publications, Oxford, 1998, 1301-1317.
Simmons-O'Brien E, Chen S, Watson R, et al. - One hundred anti-Ro (SS-A) antibody positive patients : a 10-year follow-up. Medicine, 1995, 74, 109-130.
Aringer M, Houssiau F, Gordon C, et al. - Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. Rheumatology, 2009, 48, 1451-1454.
Sparsa L, Sordet C, Chatelus H, et al. - Rhupus et traitement par anti-TNF-α : efficacité et tolérance. Données de 15 patients. Rev Rhum Mal Ostéo, 2009, 76, abstract.
Prabhakaran S, Handler R. - Lupus, "Rhupus" and "Sjrupus". J Rheumatol, 2011, 38, 39.
